Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
34.8M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
14.6M
-
Shares change
-
+3.64M
-
Total reported value, excl. options
-
$310M
-
Value change
-
+$77.1M
-
Number of buys
-
27
-
Number of sells
-
-6
-
Price
-
$21.19
Significant Holders of Disc Medicine, Inc. - COMMON STOCK (IRON) as of Q1 2023
47 filings reported holding IRON - Disc Medicine, Inc. - COMMON STOCK as of Q1 2023.
Disc Medicine, Inc. - COMMON STOCK (IRON) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.6M shares
of 34.8M outstanding shares and own 41.99% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (3.46M shares), Novo Holdings A/S (2.34M shares), ORBIMED ADVISORS LLC (2.27M shares), Bain Capital Life Sciences Investors, LLC (1.99M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (827K shares), 5AM Venture Management, LLC (588K shares), Logos Global Management LP (525K shares), VANGUARD GROUP INC (323K shares), Rock Springs Capital Management LP (313K shares), and Foresite Capital Management V, LLC (244K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.